LIJI JOBIN: Open Payments
NPI 1316291214 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 35 payments from 18 companies in 2025. Trend: 2023 $1,399 · 2024 $1,221 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $131 |
| Novo Nordisk Inc | 5 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80 |
| SANOFI-AVENTIS U.S. LLC | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $52 |
| Amgen Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $34 |
| Exact Sciences Corporation | 2 | $28 |
| Dexcom, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $24 |
Products named: JARDIANCE, TZIELD, MOUNJARO, FARXIGA, Ozempic, Wegovy, UBRELVY, OFEV.
Industry payments across TX — which companies pay providers there.
